Consortium for Top-Down Proteomics Launches Pilot Project for Characterization of Monoclonal Antibodies

Twenty-five laboratory study to illustrate the capabilities of top-down mass spectrometry in detailing monoclonal antibody structure and modifications

CAMBRIDGE, MA–(Marketwired – February 28, 2017) – The Consortium for Top Down Proteomics today announced the launch of their inter-laboratory study for characterizing monoclonal antibodies (mAbs) by top-down mass spectrometry techniques. With the continuing growth in the development and adoption of mAbs for a wide range of therapeutic uses, there is increasing demand for higher quality characterization of these complex species.

Read more